Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity.

Meltzer, Eli O; Bachert, Claus; Mayer, Michael J; Kopietz, Ferdinand; Koltun, Arkady; Maus, Joachim; D'Addio, Alexander D

Meltzer, Eli O; Bachert, Claus; Mayer, Michael J; Kopietz, Ferdinand; Koltun, Arkady; Maus, Joachim; D'Addio, Alexander D.

Afiliação

Meltzer EO; From the Department of Pediatrics, Division of Allergy and Immunology, University of California, San Diego, School of Medicine California.
Bachert C; ENT Department, Ghent University Hospital, Ghent, Belgium.
Mayer MJ; Operations, Next Breath, LLC, Baltimore, Maryland.
Kopietz F; Medical Affairs, Meda Pharma GmbH & Co. KG (a Mylan Company), Bad Homburg, Germany.
Koltun A; Global Medical Affairs, Mylan Inc., Canonsburg, Pennsylvania; and.
Maus J; Medical Affairs, Meda Pharma GmbH & Co. KG (a Mylan Company), Bad Homburg, Germany.
D'Addio AD; Research & Development, Meda Pharmaceuticals, Somerset, New Jersey.

Allergy Asthma Proc ; 41(4): 265-270, 2020 07 01.

Article em En | MEDLINE | ID: mdl-32393418

Assuntos

Antiasmáticos/administração & dosagem; Fluticasona/administração & dosagem; Modelos Anatômicos; Cavidade Nasal; Sprays Nasais; Ftalazinas/administração & dosagem; Administração Intranasal; Humanos; Técnicas In Vitro

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Ftalazinas / Antiasmáticos / Sprays Nasais / Fluticasona / Modelos Anatômicos / Cavidade Nasal Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Allergy Asthma Proc Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google